
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Virotec Intl | LSE:VTI | London | Ordinary Share | GB00B15PVR02 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:6106V Virotec International PLC 27 April 2007 VIROTEC INTERNATIONAL PLC 26 April 2007 ISSUES OF SECURITIES Virotec International plc ("Virotec") (AIM:VTI) advises that it has issued the following securities: 6,655,789 Ordinary shares of 1p each issued at a price of #0.14 per share to the incentive plans for executives as approved by shareholders at the Annual General Meeting on 28 November 2003. 7,000,000 Options exercisable at a price of #0.20 each vesting over 5 years between April 2007 and April 2011 subject to the achievement of performance criteria and expiring 3 years after vesting, to the recently appointed CEO, Dr Lee Fergusson, which forms part of his remuneration package for his new position. 3,400,000 Options exercisable at a price of #0.20 each on or before 30 April 2012 issued to directors and employees pursuant to the Virotec Option Incentive Scheme. Application will be been made for the 6,655,789 New Ordinary Shares of 1p each to be admitted to trading on the AIM market of the London Stock Exchange. The New Ordinary Shares will rank pari passu with existing ordinary shares and it is expected that admission will become effective at 8.00 a.m. on Tuesday 1 May 2007. All of the options noted above were issued to employees pursuant to the Virotec Option Incentive Scheme (the "Scheme"). Under the terms of the Scheme, options can generally only be exercised by employees during two periods each year, being one month immediately following the release of the half year and one month immediately following the release of the full year financial results. The following options have lapsed or have been cancelled: 5,000,000 Options exercisable at a price of #0.40 each at various times between 1 July 2006 and 30 September 2015 to senior executives. 150,000 Options exercisable at #0.20 each on or before 30 September 2006. 10,000 Options exercisable at #0.20 each on or before 31 March 2007. 110,000 Options exercisable at #0.20 each on or before 30 September 2007. 110,000 Options exercisable at #0.28 each on or before 31 March 2009. Following successful completion of the placing announced on 28 March 2007 of 17,350,000 ordinary shares, the current issued capital of Virotec following the issue of the securities referred to above comprises: 264,168,231 Ordinary shares of 1p each; and 16,480,000 Options with various expiry dates between 30 September 2007 and 30 April 2014 and exercisable at prices between #0.20 and #0.40 each. Angus Craig Company Secretary VIROTEC INTERNATIONAL PLC PO BOX 188 SANCTUARY COVE QLD 4212 AUSTRALIA www.virotec.com This information is provided by RNS The company news service from the London Stock Exchange END IOEOKAKBABKDCQB
1 Year Virotec Chart |
1 Month Virotec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions